project id: TCGA-KIRP; case submitter id: TCGA-SX-A7SR; source center: 23; state: released; a260 a280 ratio: 1.98; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.59; rna integrity number: 7.4; age at index: 66; days to birth: -24237; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 24237; ajcc clinical m: M0; ajcc clinical n: NX; ajcc clinical stage: Stage II; ajcc clinical t: T2a; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 805.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 2.73972602739726; pack years smoked: 50.0; is ffpe: false; composition: Not Reported; days to collection: 526; days to sample procurement: 0; initial weight: 170.0; portion submitter id: TCGA-SX-A7SR-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 85.0; percent tumor nuclei: 90.0;